Treatment for periodontitis
The present invention relates to compositions and their use for oral care. In particular, the compositions and methods are for maintaining oral health and/or treating various oral conditions such as gingivitis. The present invention relates to methods and uses of stabilized amorphous calcium phosphate (ACP) and/or stabilized amorphous calcium fluoride phosphate (ACFP) in the preparation of a medicament for reducing pathogenic oral bacteria at an oral site in an individual; increasing commensal oral bacteria at an oral site in an individual; decreasing the proportion of pathogenic oral bacteria at an oral site in an individual; inhibiting oral dysbiosis; reducing gingival inflammation in an individual in need thereof; treating gingivitis in an individual in need thereof; and treating chronic gingivitis in an individual in need thereof.
1. A method of treating periodontitis in an individual in need thereof having at least moderate periodontitis, the method comprising administering one or both of stabilized amorphous calcium phosphate (ACP) and stabilized amorphous calcium fluoride phosphate (ACFP) to the oral cavity of the individual, thereby treating periodontitis, wherein the stabilized ACP is not a stannous-associated phosphopeptide (PP) stabilized amorphous calcium phosphate (ACP) and the stabilized ACFP is not a stannous-associated phosphopeptide (PP) stabilized amorphous calcium fluoride phosphate (ACFP).
2. The method according to claim 1 , wherein the method further comprises, prior to the administering, an initial step of identifying the individual as having at least moderate periodontitis.
3. The method according to claim 1 , wherein the method further comprises, prior to the administering, performing a dental procedure on the individual.
4. The method according to claim 3 , wherein the dental procedure is selected from debridement, scaling, root planing, and any other procedure to remove subgingival or supragingival bacteria.
5. The method according to claim 1 , wherein the stabilized amorphous calcium phosphate (ACP) is phosphopeptide stabilized and the stabilized amorphous calcium fluoride phosphate (ACFP) is phosphopeptide stabilized.
6. The method according to claim 5 , wherein the phosphopeptide is a casein phosphopeptide.
7. The method according to claim 1 , wherein the method comprises administering the stabilized amorphous calcium phosphate (ACP) and/or stabilized amorphous calcium fluoride phosphate (ACFP) in any one of the following types of compositions:
toothpastes, toothpowders, liquid dentifrices, mouthwashes, mouthrinses, mouth sprays, varnish, dental cement, troches, chewing gums, dental pastes, gingival massage creams, gargle tablets, dairy products and other foodstuffs.
8. The method according to claim 7 , wherein the composition is a chewing gum.
9. The method according to claim 8 , wherein the chewing gum contains and amount of ACP or ACFP selected from about 15 mg, 20 mg, 25 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 55 mg and 60 mg.
10. The method according to claim 9 , wherein the chewing gum contains about 18.8 or about 56.4 mg of stabilized ACP or ACFP.
11. The method according to claim 1 , wherein the individual in need thereof has moderate periodontitis.
12. The method according to claim 1 , wherein the individual in need thereof has severe periodontitis.